Aberrant EGFR activation frequently occurs in diverse malignancies, including lung cancer [11,12,13], and triggers a series of tumorigenic events, such as cell proliferation, cell invasion, and metastasis and angiogenesis [14,15,16]. The gene discussed is EGFR; the disease is lung cancer.